2676865-18-0 Usage
Uses
Used in Organic Synthesis:
(4-nitro-1,2,3,5,6,7-hexahydro-s-indacen-2-yl)methanol is used as a building block in organic synthesis for the creation of various complex organic molecules. Its unique structure allows for versatile chemical reactions and the formation of a wide range of compounds.
Used in Pharmaceutical Production:
(4-nitro-1,2,3,5,6,7-hexahydro-s-indacen-2-yl)methanol is used as an intermediate in the production of pharmaceuticals. Its presence in the synthesis of certain drugs can contribute to their therapeutic effects and properties.
Used in Agrochemical Production:
(4-nitro-1,2,3,5,6,7-hexahydro-s-indacen-2-yl)methanol is used as a precursor in the synthesis of agrochemicals, such as pesticides and herbicides. Its unique structure can be utilized to create effective and targeted agrochemicals.
Used in Medicinal Chemistry and Drug Discovery:
(4-nitro-1,2,3,5,6,7-hexahydro-s-indacen-2-yl)methanol is used as a research compound in the field of medicinal chemistry and drug discovery. Its unique structure and properties make it a valuable tool for studying potential therapeutic agents and their mechanisms of action.
Used in Pharmacological and Toxicological Studies:
(4-nitro-1,2,3,5,6,7-hexahydro-s-indacen-2-yl)methanol is used in pharmacological and toxicological studies to investigate its potential uses and safety considerations. Understanding its effects on biological systems can provide valuable insights into its potential applications and limitations in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 2676865-18-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 2,6,7,6,8,6 and 5 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 2676865-18:
(9*2)+(8*6)+(7*7)+(6*6)+(5*8)+(4*6)+(3*5)+(2*1)+(1*8)=240
240 % 10 = 0
So 2676865-18-0 is a valid CAS Registry Number.
2676865-18-0Relevant articles and documents
SULFONIMIDAMIDE COMPOUNDS AS NLRP3 MODULATORS
-
Paragraph 0927; 0929, (2021/07/31)
Described herein are compounds of Formula (I), Formula (I-A), and Formula (I-B), solvates thereof, tautomers thereof, and pharmaceutically acceptable salts of the foregoing, Further described herein are methods of inhibiting NLRP3 using said compounds, and methods of and compositions useful in treating NLRP3-dependent disorders.
